LENSAR Cash Flow from Investing Activities 2019-2024 | LNSR
LENSAR cash flow from investing activities from 2019 to 2024. Cash flow from investing activities can be defined as the total change in cash resulting from a companies investments
| LENSAR Annual Cash Flow Investing (Millions of US $) |
|
|---|---|
| 2024 | $-2 |
| 2023 | $-4 |
| 2022 | $0 |
| 2021 | $0 |
| 2020 | $0 |
| 2019 | $-2 |
| 2018 | $-4 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $0.165B | $0.053B |
| LENSAR Inc. is a commercial-stage medical device company. It focuses on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. LENSAR Inc. is based in Orlando, Florida. | |||